Meera R Chappidi1, Max Kates2, C J Stimson2, Michael H Johnson2, Phillip M Pierorazio2, Trinity J Bivalacqua2. 1. James Buchanan Brady Urological Institute and Department of Urology, The Johns Hopkins University School of Medicine, Baltimore, Maryland. Electronic address: mchappi1@jhmi.edu. 2. James Buchanan Brady Urological Institute and Department of Urology, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
Abstract
PURPOSE: We compared the timing, causes, hospital costs and perioperative outcomes of index vs nonindex hospital readmissions after radical cystectomy. MATERIALS AND METHODS: The 2013 Nationwide Readmissions Database was queried for patients with bladder cancer undergoing cystectomy. Sociodemographic characteristics, hospital costs and causes of readmission were compared among index and nonindex readmitted patients. Univariable and multivariable logistic regression models were used to identify predictors of nonindex readmissions, mortality during the first readmission and subsequent readmission. RESULTS: Among 4,991 patients identified 29% (1,447) and 11% (571) experienced an index and nonindex readmission, respectively. Compared to index readmissions, nonindex readmissions were more likely late readmissions (p <0.001) of older patients (p=0.047) who underwent cystectomy at higher volume hospitals (p=0.02) and were readmitted to hospitals located in less populated areas (p <0.001). Compared to index readmissions the percentage of nonindex readmissions for cardiovascular complications was higher (7.6% vs 2.9%, p=0.003), while the percentage of nonindex readmissions for gastrointestinal (6.0% vs 11.0%, p=0.04) and wound (5.3% vs 16.7%, p=0.0001) complications was lower. Predictors of nonindex readmission included longer length of stay (OR 1.02; 95% CI 1.001, 1.04), patient location in less populated areas, nonteaching hospital (OR 0.52; 95% CI 0.31, 0.86) and discharge to facility (OR 2.82; 95% CI 1.75, 4.55) or with home health (OR 1.49; 95% CI 1.05, 2.10). Nonindex readmissions had comparable mean readmission hospital costs ($14,147 vs $15,102, p=0.7), in-hospital mortality (OR 1.11; 95% CI 0.42, 2.87) and subsequent readmission (OR 1.32; 95% CI 0.87, 2.00) to index readmissions. CONCLUSIONS: This nationally representative study of patients undergoing radical cystectomy demonstrated comparable perioperative outcomes and hospital costs between index and nonindex readmitted patients, which supports the continued regionalization of cystectomy care.
PURPOSE: We compared the timing, causes, hospital costs and perioperative outcomes of index vs nonindex hospital readmissions after radical cystectomy. MATERIALS AND METHODS: The 2013 Nationwide Readmissions Database was queried for patients with bladder cancer undergoing cystectomy. Sociodemographic characteristics, hospital costs and causes of readmission were compared among index and nonindex readmitted patients. Univariable and multivariable logistic regression models were used to identify predictors of nonindex readmissions, mortality during the first readmission and subsequent readmission. RESULTS: Among 4,991 patients identified 29% (1,447) and 11% (571) experienced an index and nonindex readmission, respectively. Compared to index readmissions, nonindex readmissions were more likely late readmissions (p <0.001) of older patients (p=0.047) who underwent cystectomy at higher volume hospitals (p=0.02) and were readmitted to hospitals located in less populated areas (p <0.001). Compared to index readmissions the percentage of nonindex readmissions for cardiovascular complications was higher (7.6% vs 2.9%, p=0.003), while the percentage of nonindex readmissions for gastrointestinal (6.0% vs 11.0%, p=0.04) and wound (5.3% vs 16.7%, p=0.0001) complications was lower. Predictors of nonindex readmission included longer length of stay (OR 1.02; 95% CI 1.001, 1.04), patient location in less populated areas, nonteaching hospital (OR 0.52; 95% CI 0.31, 0.86) and discharge to facility (OR 2.82; 95% CI 1.75, 4.55) or with home health (OR 1.49; 95% CI 1.05, 2.10). Nonindex readmissions had comparable mean readmission hospital costs ($14,147 vs $15,102, p=0.7), in-hospital mortality (OR 1.11; 95% CI 0.42, 2.87) and subsequent readmission (OR 1.32; 95% CI 0.87, 2.00) to index readmissions. CONCLUSIONS: This nationally representative study of patients undergoing radical cystectomy demonstrated comparable perioperative outcomes and hospital costs between index and nonindex readmitted patients, which supports the continued regionalization of cystectomy care.
Authors: Brent K Hollenbeck; David C Miller; David Taub; Rodney L Dunn; Shukri F Khuri; William G Henderson; James E Montie; Willie Underwood; John T Wei Journal: J Urol Date: 2005-10 Impact factor: 7.450
Authors: Chaoyi Zheng; Elizabeth B Habermann; Nawar M Shara; Russell C Langan; Young Hong; Lynt B Johnson; Waddah B Al-Refaie Journal: J Am Coll Surg Date: 2016-02-05 Impact factor: 6.113
Authors: Ahmed M Harraz; Yasser Osman; Samer El-Halwagy; Mahmoud Laymon; Ahmed Mosbah; Hassan Abol-Enein; Atalla A Shaaban Journal: BJU Int Date: 2014-08-16 Impact factor: 5.588
Authors: Matthew E Nielsen; Katherine Mallin; Mark A Weaver; Bryan Palis; Andrew Stewart; David P Winchester; Matthew I Milowsky Journal: BJU Int Date: 2014-05-22 Impact factor: 5.588
Authors: Yuhree Kim; Faiz Gani; Donald J Lucas; Aslam Ejaz; Gaya Spolverato; Joseph K Canner; Eric B Schneider; Timothy M Pawlik Journal: Ann Surg Date: 2015-09 Impact factor: 12.969
Authors: Jim C Hu; Bilal Chughtai; Padraic O'Malley; Joshua A Halpern; Jialin Mao; Douglas S Scherr; Dawn L Hershman; Jason D Wright; Art Sedrakyan Journal: Eur Urol Date: 2016-04-28 Impact factor: 20.096
Authors: Katharine L Jackson; Robert E Glasgow; Britani R Hill; Mary C Mone; Bradford Sklow; Courtney L Scaife; Xiaoming Sheng; William J Peche Journal: Dis Colon Rectum Date: 2013-03 Impact factor: 4.585
Authors: Austin M Tang; Joshua Bakhsheshian; Li Ding; Casey A Jarvis; Edith Yuan; Ben Strickland; Steven L Giannotta; Arun Amar; Frank J Attenello; William J Mack Journal: World Neurosurg Date: 2019-07-05 Impact factor: 2.104
Authors: Peter S Kirk; Ted A Skolarus; Bruce L Jacobs; Yongmei Qin; Benjamin Li; Michael Sessine; Xiang Liu; Kevin Zhu; Scott M Gilbert; Brent K Hollenbeck; Ken Urish; Jonathan Helm; Mariel S Lavieri; Tudor Borza Journal: BJU Int Date: 2019-08-11 Impact factor: 5.588
Authors: Niv Milbar; Max Kates; Meera R Chappidi; Filippo Pederzoli; Takahiro Yoshida; Alexander Sankin; Phillip M Pierorazio; Mark P Schoenberg; Trinity J Bivalacqua Journal: Bladder Cancer Date: 2017-10-27